{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68083-696",
      "generic_name": "Buprenorphine hydrochloride",
      "labeler_name": "Gland Pharma Limited",
      "dea_schedule": "CIII",
      "brand_name": "Buprenorphine hydrochloride",
      "active_ingredients": [
        {
          "name": "BUPRENORPHINE HYDROCHLORIDE",
          "strength": ".324 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68083-696-05",
          "description": "5 VIAL in 1 CARTON (68083-696-05)  / 1 mL in 1 VIAL",
          "marketing_start_date": "20261015",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "INJECTION",
      "spl_id": "47e07da7-bfd9-42ea-89dd-b814f546add3",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20261015",
      "product_id": "68083-696_47e07da7-bfd9-42ea-89dd-b814f546add3",
      "application_number": "ANDA221145",
      "brand_name_base": "Buprenorphine hydrochloride",
      "pharm_class": [
        "Partial Opioid Agonist [EPC]",
        "Partial Opioid Agonists [MoA]"
      ]
    }
  ]
}